The foundation Stichting Eigen Regie, (kvk) 70567573 was established on januari 8 th 2018. It's core activities were wound management in elderly care.The development of anti-infectives gained momentum during the Covid pandemic.  As a start-up, BeneluxBio does its own in-house research and has licensed compounds from Liberpharma. Liberpharma became in 2022 the trading name of the Stichting Eigen Regie. With a commitment to innovation and patient care, we aim to develop new medicines that address infectious diseases,epilepsy in cooperation with the University of Maastricht, and multiple myeloma ( via molecular glues).Many compounds  were designed and developed under a program of the NCI.Director is mr. J.H.A. Cornelesen
We are gratefull to our former director mr. R.G. Dassen(Itteren,Netherlands)for his relentless commitment to the Stichting Eigen Regie